ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ONXX Onyx Pharmaceuticals, Inc. (MM)

124.70
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Onyx Pharmaceuticals, Inc. (MM) NASDAQ:ONXX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 124.70 0 01:00:00

Onyx Pharmaceuticals Announces Third Quarter 2004 Financial Results Webcast and Teleconference

01/11/2004 9:00pm

PR Newswire (US)


Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Onyx Pharmaceuticals, Inc. (MM) Charts.
Onyx Pharmaceuticals Announces Third Quarter 2004 Financial Results Webcast and Teleconference RICHMOND, Calif., Nov. 1 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that it will webcast a teleconference discussing its third quarter 2004 financial results on Thursday, November 4, 2004, at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Financial results for the third quarter ended September 30, 2004 will be released earlier that day. Interested parties may access a live webcast of the presentation at: http://phx.corporate-ir.net/playerlink.zhtml?c=112065&s=wm&e=961508 or by dialing 617-614-4911 and using the passcode 24169366. A replay of the presentation will be available on the Onyx website or by dialing 617-801-6888 and using the passcode 92061130 approximately one hour after the teleconference concludes. The replay will be available through December 4, 2004. Onyx Pharmaceuticals is engaged in the development of novel cancer therapies that target the molecular basis of cancer. With its collaborators, the company is developing small molecule drugs, including BAY 43-9006 with Bayer Pharmaceuticals Corporation. For more information about Onyx's pipeline and activities, visit the company's website at http://www.onyx-pharm.com/. DATASOURCE: Onyx Pharmaceuticals, Inc. CONTACT: Julie Wood, +1-510-262-8757, or Alexandra Santos, +1-510-243-3695, both for Onyx Pharmaceuticals, Inc. Web site: http://www.onyx-pharm.com/

Copyright

1 Year Onyx Pharmaceuticals, Inc. (MM) Chart

1 Year Onyx Pharmaceuticals, Inc. (MM) Chart

1 Month Onyx Pharmaceuticals, Inc. (MM) Chart

1 Month Onyx Pharmaceuticals, Inc. (MM) Chart